Table 2 Expression of various kinases in AA and EA patients with TNBC (TCGA dataset).

From: PLK1 and AURKB phosphorylate survivin differentially to affect proliferation in racially distinct triple-negative breast cancer

Sr. no

Gene

Below threshold

P-value

1

ABL1

No

0.376

2

AKT1

No

0.153

3

AKT2

No

0.327

4

AKT3

No

0.151

5

ALK

No

0.701

6

AURKA

No

0.732

7

AURKB

Yes

0.001

8

AURKC

No

0.681

9

BTK

No

0.307

10

CDK1

No

0.914

11

CDKN1A

No

0.919

12

CHKA

No

0.296

13

CHKB

No

0.133

14

SRC

No

0.243

15

EGFR

No

0.198

16

ERBB2

No

0.413

17

FES

No

0.023

18

FGFR1

No

0.576

19

FGFR2

No

0.265

20

FGFR3

No

0.752

21

FGFR4

No

0.943

22

PIK3CA

No

0.13

23

JAK2

No

0.448

24

KIT

No

0.126

25

MAPK1

No

0.225

26

MAPK3

No

0.28

27

MAP2K1

No

0.868

28

MTOR

No

0.015

29

NFKB1

No

0.046

30

PDGFRA

No

0.369

31

PDGFRB

No

0.549

32

PIK3CA

No

0.13

33

PRKCI

No

0.095

34

PLK1

Yes

0.026

35

PLK2

No

0.528

36

PLK3

No

0.178

37

PLK4

No

0.069

38

PIK3CG

No

0.591

39

ROCK1

No

0.027

40

RPS6KA3

No

0.126

41

SYK

No

0.233

42

SRC

No

0.243

43

NTRK2

No

0.423

44

KDR

No

0.047